Skip to content
healthcare.dev

Monobasic Sodium Phosphate and Dibasic Sodium Phosphate

NDC 43386-030, Monobasic Sodium Phosphate and Dibasic Sodium Phosphate, tablet, from Lupin Pharmaceuticals,Inc..

Product NDC
43386-030
Status
Listed
Labeler
Lupin Pharmaceuticals,Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079247
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43386-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE1.105 g/1
  • SODIUM PHOSPHATE, DIBASIC, ANHYDROUS.398 g/1

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e2fcc382-6fac-4438-ad02-ebc8528dd59a

Use it

Look up 43386-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43386-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43386-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.